Trial Profile
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Bridge to Transplant Patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Rexlemestrocel-L (Primary)
- Indications Heart failure
- Focus Adverse reactions
- 21 Nov 2014 New trial record